Ceftriaxone1000 mg + Sulbactam 500 mg
vial
Rs. 160
LV-CEF-S is a combination of Ceftriaxone, a third-generation cephalosporin antibiotic, and Sulbactam, a beta-lactamase inhibitor. This dual-action formulation is designed to effectively combat a wide range of serious bacterial infections by both killing the bacteria and protecting the antibiotic from degradation by resistant organisms. Ceftriaxone interferes with bacterial cell wall synthesis, leading to cell death, while Sulbactam neutralizes beta-lactamase enzymes that can render antibiotics ineffective.
It is commonly prescribed for respiratory tract infections, urinary tract infections, gynecological infections, skin and soft tissue infections, and septicemia. The combination increases the spectrum of action and is effective against both gram-positive and gram-negative bacteria.
LV-CEF-S is ideal for hospital settings where prompt and effective treatment is critical. Its broad-spectrum activity ensures faster recovery in moderate to severe infections.
